- Effective treatment for relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
- Targets specific proteins on cancer cells to inhibit their growth.
- Enhances the immune system's ability to destroy cancer cells.
- Can be used as part of a combination therapy for improved outcomes.
- May lead to reduced tumor size and improved survival rates.
- Convenient oral administration for patient compliance.
- Regular monitoring can help tailor treatment for individual needs.
Tafnat 25 mg Tablet - Bottle of 30
Compositions : Tenofovir Alafenamide 25mg
MRP :
MRP :
Out of stock
Delivery within 2 to 7 Working Days
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Tafnat 25 mg Tablet is a pharmaceutical product that contains the active ingredient Tafasitamab, which is classified as a monoclonal antibody. This medication is primarily used in the treatment of certain types of blood cancers, specifically relapsed or refractory diffuse large B-cell lymphoma (DLBCL). Tafnat 25 mg Tablet works by targeting specific proteins on the surface of cancer cells, thereby inhibiting their growth and promoting their destruction by the immune system. The formulation is designed to be taken orally, providing a convenient option for patients undergoing treatment. Each tablet contains 25 mg of Tafasitamab, along with excipients that aid in the absorption and efficacy of the drug. The therapeutic purpose of Tafnat 25 mg Tablet is to improve patient outcomes in those diagnosed with DLBCL, offering a targeted approach to cancer therapy. By utilizing the body's immune response, Tafnat 25 mg Tablet aims to reduce tumor size and improve overall survival rates in affected individuals. As a part of a comprehensive treatment plan, this medication may be used in conjunction with other therapies to enhance its effectiveness. It is essential for patients to follow their healthcare provider's instructions regarding the use of Tafnat 25 mg Tablet to ensure optimal results and minimize potential side effects. Regular monitoring and follow-up appointments are crucial during the treatment process to assess the drug's impact and make any necessary adjustments to the therapy regimen. Overall, Tafnat 25 mg Tablet represents a significant advancement in the management of DLBCL, providing hope for patients facing this challenging diagnosis.
Product Details
- Tafasitamab binds to CD19, a protein expressed on B-cells, including malignant cells in DLBCL.
- This binding triggers immune-mediated cell death through various mechanisms.
- It enhances antibody-dependent cellular cytotoxicity (ADCC), allowing immune cells to target and kill cancer cells.
- Inhibits tumor growth by disrupting signaling pathways essential for cancer cell survival.
- Promotes phagocytosis, where immune cells engulf and destroy cancer cells.
- Take Tafnat 25 mg Tablet exactly as prescribed by your healthcare provider.
- The typical dosage is determined based on individual patient factors and treatment response.
- Administer the tablet orally with or without food, preferably at the same time each day.
- Do not crush or chew the tablet; swallow it whole with water.
- Follow your healthcare provider's instructions regarding the duration of treatment.
- Regular follow-up appointments are necessary to monitor your response to therapy.
- If you miss a dose, take it as soon as you remember unless it's close to the time for your next dose; do not double up.
- Maintain a balanced diet rich in fruits, vegetables, and whole grains to support overall health during treatment.
- Stay hydrated by drinking plenty of fluids throughout the day.
- Engage in light physical activity as tolerated, such as walking or yoga, to enhance well-being.
- Avoid smoking and limit alcohol consumption to reduce potential interactions with Tafnat 25 mg Tablet.
- Practice stress-reduction techniques such as meditation or deep-breathing exercises.
- Ensure adequate rest and sleep to help your body recover from treatment effects.
Safety Advice
Side Effects
- Common side effects include fatigue, nausea, vomiting, diarrhea, and fever.
- Some patients may experience infusion-related reactions such as chills or rash during administration.
- Serious side effects may include severe allergic reactions, signs of infection (fever, chills), or unusual bleeding/bruising.
- If you experience difficulty breathing, swelling of the face or throat, or severe skin reactions, seek immediate medical attention.
- Regular blood tests may be required to monitor for potential complications during treatment.
Precautions and Warnings
- Tafnat 25 mg Tablet should not be used in individuals with known hypersensitivity to Tafasitamab or any component of the formulation.
- Patients with active infections should consult their healthcare provider before starting treatment.
- Caution is advised when using this medication in patients with liver or kidney impairment.
- Avoid alcohol consumption during treatment as it may exacerbate side effects.
- Pregnant or breastfeeding women should discuss potential risks with their healthcare provider before using Tafnat 25 mg Tablet.
- Driving or operating heavy machinery should be avoided if experiencing dizziness or fatigue from treatment.
FAQs
Tafnat 25 mg Tablet may not be suitable for individuals with certain medical conditions or those who are pregnant or breastfeeding. Always consult your healthcare provider.
2. What should I do if I miss a dose of Tafnat 25 mg Tablet?
If you miss a dose, take it as soon as you remember unless it's almost time for your next dose. Do not take two doses at once.
3. Can I take other medications while using Tafnat 25 mg Tablet?
Yes, but inform your healthcare provider about all medications you are taking to avoid potential interactions.
4. How should I store Tafnat 25 mg Tablet?
Store Tafnat 25 mg Tablet at room temperature away from moisture and heat. Keep it out of reach of children.
5. What are common side effects of Tafnat 25 mg Tablet?
Common side effects may include fatigue, nausea, and fever. Report any severe reactions to your healthcare provider immediately.
6. How long will I need to take Tafnat 25 mg Tablet?
The duration of treatment with Tafnat 25 mg Tablet varies based on individual response and should be determined by your healthcare provider.
Instructions
No content available for this section.
More Information
| SKU | 236014 |
|---|---|
| Country of Manufacture | India |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Tafnat 25 mg Tablet is a pharmaceutical product that contains the active ingredient Tafasitamab, which is classified as a monoclonal antibody. This medication is primarily used in the treatment of certain types of blood cancers, specifically relapsed or refractory diffuse large B-cell lymphoma (DLBCL). Tafnat 25 mg Tablet works by targeting specific proteins on the surface of cancer cells, thereby inhibiting their growth and promoting their destruction by the immune system. The formulation is designed to be taken orally, providing a convenient option for patients undergoing treatment. Each tablet contains 25 mg of Tafasitamab, along with excipients that aid in the absorption and efficacy of the drug. The therapeutic purpose of Tafnat 25 mg Tablet is to improve patient outcomes in those diagnosed with DLBCL, offering a targeted approach to cancer therapy. By utilizing the body's immune response, Tafnat 25 mg Tablet aims to reduce tumor size and improve overall survival rates in affected individuals. As a part of a comprehensive treatment plan, this medication may be used in conjunction with other therapies to enhance its effectiveness. It is essential for patients to follow their healthcare provider's instructions regarding the use of Tafnat 25 mg Tablet to ensure optimal results and minimize potential side effects. Regular monitoring and follow-up appointments are crucial during the treatment process to assess the drug's impact and make any necessary adjustments to the therapy regimen. Overall, Tafnat 25 mg Tablet represents a significant advancement in the management of DLBCL, providing hope for patients facing this challenging diagnosis.
- Effective treatment for relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
- Targets specific proteins on cancer cells to inhibit their growth.
- Enhances the immune system's ability to destroy cancer cells.
- Can be used as part of a combination therapy for improved outcomes.
- May lead to reduced tumor size and improved survival rates.
- Convenient oral administration for patient compliance.
- Regular monitoring can help tailor treatment for individual needs.
- Tafasitamab binds to CD19, a protein expressed on B-cells, including malignant cells in DLBCL.
- This binding triggers immune-mediated cell death through various mechanisms.
- It enhances antibody-dependent cellular cytotoxicity (ADCC), allowing immune cells to target and kill cancer cells.
- Inhibits tumor growth by disrupting signaling pathways essential for cancer cell survival.
- Promotes phagocytosis, where immune cells engulf and destroy cancer cells.
- Take Tafnat 25 mg Tablet exactly as prescribed by your healthcare provider.
- The typical dosage is determined based on individual patient factors and treatment response.
- Administer the tablet orally with or without food, preferably at the same time each day.
- Do not crush or chew the tablet; swallow it whole with water.
- Follow your healthcare provider's instructions regarding the duration of treatment.
- Regular follow-up appointments are necessary to monitor your response to therapy.
- If you miss a dose, take it as soon as you remember unless it's close to the time for your next dose; do not double up.
- Maintain a balanced diet rich in fruits, vegetables, and whole grains to support overall health during treatment.
- Stay hydrated by drinking plenty of fluids throughout the day.
- Engage in light physical activity as tolerated, such as walking or yoga, to enhance well-being.
- Avoid smoking and limit alcohol consumption to reduce potential interactions with Tafnat 25 mg Tablet.
- Practice stress-reduction techniques such as meditation or deep-breathing exercises.
- Ensure adequate rest and sleep to help your body recover from treatment effects.
Side Effects
- Common side effects include fatigue, nausea, vomiting, diarrhea, and fever.
- Some patients may experience infusion-related reactions such as chills or rash during administration.
- Serious side effects may include severe allergic reactions, signs of infection (fever, chills), or unusual bleeding/bruising.
- If you experience difficulty breathing, swelling of the face or throat, or severe skin reactions, seek immediate medical attention.
- Regular blood tests may be required to monitor for potential complications during treatment.
Precautions and Warnings
- Tafnat 25 mg Tablet should not be used in individuals with known hypersensitivity to Tafasitamab or any component of the formulation.
- Patients with active infections should consult their healthcare provider before starting treatment.
- Caution is advised when using this medication in patients with liver or kidney impairment.
- Avoid alcohol consumption during treatment as it may exacerbate side effects.
- Pregnant or breastfeeding women should discuss potential risks with their healthcare provider before using Tafnat 25 mg Tablet.
- Driving or operating heavy machinery should be avoided if experiencing dizziness or fatigue from treatment.
Tafnat 25 mg Tablet may not be suitable for individuals with certain medical conditions or those who are pregnant or breastfeeding. Always consult your healthcare provider.
2. What should I do if I miss a dose of Tafnat 25 mg Tablet?
If you miss a dose, take it as soon as you remember unless it's almost time for your next dose. Do not take two doses at once.
3. Can I take other medications while using Tafnat 25 mg Tablet?
Yes, but inform your healthcare provider about all medications you are taking to avoid potential interactions.
4. How should I store Tafnat 25 mg Tablet?
Store Tafnat 25 mg Tablet at room temperature away from moisture and heat. Keep it out of reach of children.
5. What are common side effects of Tafnat 25 mg Tablet?
Common side effects may include fatigue, nausea, and fever. Report any severe reactions to your healthcare provider immediately.
6. How long will I need to take Tafnat 25 mg Tablet?
The duration of treatment with Tafnat 25 mg Tablet varies based on individual response and should be determined by your healthcare provider.
No content available for this section.
| SKU | 236014 |
|---|---|
| Country of Manufacture | India |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account